12 Cash-Rich Penny Stocks To Buy According To Hedge Funds

Page 5 of 10

6. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

TTM Operating Cash Flow as of December 31, 2024: $29,893,000

Number of Hedge Fund Holders: 25

Share Price as of March 4: $3.065

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) provides products for drug development, diagnostics, and biopharma research. The company specializes in nucleic acid production, providing RNA and DNA products for gene therapy, vaccines, and molecular diagnostics. It also focuses on biologics safety testing, offering tools to detect impurities in biopharmaceutical manufacturing. MRVI is one of the best cash-rich stocks to monitor.

On January 28, 2025, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) acquired key assets from Molecular Assemblies to strengthen its work in next-gen mRNA and CRISPR therapies. CEO Trey Martin emphasized Molecular Assemblies’ innovative enzymatic DNA synthesis technology and Maravai’s plans to enhance it with TriLink and Alphazyme resources.

Among the hedge funds tracked by Insider Monkey’s fourth quarter database, 25 funds reported owning stakes in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), compared to 31 funds in the prior quarter. 12 West Capital Management was the biggest stakeholder of the company, with 11.6 million shares worth $63 million.

Page 5 of 10